INOZYME PHARMA, INC. Long-term Debt, Gross
INOZYME PHARMA, INC. had Long-term Debt, Gross of $45.00 million as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2025-05-14
- 2024-12-31: Long-term Debt, Gross $45.00M.
- 2024-09-30: Long-term Debt, Gross $45.00M.
- 2024-06-30: Long-term Debt, Gross $45.00M.
- 2024-03-31: Long-term Debt, Gross $45.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2024-12-31 | $45.00M 10-K · filed 2025-03-10 |
| 2024-09-30 | $45.00M 10-Q · filed 2025-05-14 |
| 2024-06-30 | $45.00M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $45.00M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $45.00M 10-K · filed 2024-03-12 |
| 2023-09-30 | $32.50M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $32.50M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $25.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $5.00M 10-K · filed 2023-03-22 |
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-10 |